Circle Program Components

Abstinence Based Focus - We help patients learn to manage their anxiety, attention problems and chronic pain without the use of addictive medications. Patients must not be currently using benzodiazepines, stimulants (Ritalin, etc.) and narcotics for pain management before admission. People on methadone or buprenorphine maintenance prior to admission may continue on this form of treatment if approved by the Circle Program medical director.

Behavior Awareness - Patients in this program are required to take responsibility for changing the behaviors that perpetuate chemical dependence and to learn management skills for mental illness. Patients are expected to report to treatment staff any behaviors, attitudes or rule infractions that are destructive to the recovery process, whether on their part or on the part of other patients.

Tobacco - We treat nicotine use as seriously, and in the same fashion, as any other drug addiction. Patients are not allowed to use tobacco products during their treatment and are encouraged to remain tobacco free after discharge. Circle has been tobacco-free since January 2000 and as of June, 2008, CMHIP is a tobacco-free campus.

Psychiatric Treatment - Patients learn signs and symptoms of their mental illness and or personality disorders and how substance abuse interferes with good mental health and stability. In every aspect of the program, mental illness and substance abuse are fully integrated and addressed. Patients participate as a partner in the decision for medication to encourage understanding of the need for medication compliance.